Literature DB >> 7295229

Electrophysiological assessment of compressive lesions of anterior visual pathways.

D J Stark, L Lenton.   

Abstract

The findings in the pattern reversal V.E.C.P.'s have been examined in thirteen (13) patients, with proven or suspected pituitary tumours. Three (3) of these cases have been examined in detail, to highlight the unique capabilities of the pattern reversal V.E.C.P. in the assessment of conduction abnormalities of optic nerve and chiasma, due to compression by pituitary tumours. The V.E.C.P. is shown to be a uniquely sensitive procedure, which yields objective and quantitative data about the functional status of the anterior visual pathways, in cases of suspected compression by pituitary tumours. It is suggested that subclinical optic nerve compression is best detected by serially monitoring optic nerve conduction with the pattern reversal V.E.C.P.

Entities:  

Mesh:

Year:  1981        PMID: 7295229

Source DB:  PubMed          Journal:  Aust J Ophthalmol        ISSN: 0310-1177


  5 in total

1.  Visual evoked potentials in the assessment of patients with non-functioning chromophobe adenomas.

Authors:  G E Holder; P R Bullock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

2.  Pre- and postoperative findings of pattern VECPs and ERGs in patients of orbital tumors.

Authors:  A Mizota; E Adachi-Usami; Y Kakisu; K Asanagi
Journal:  Doc Ophthalmol       Date:  1988-05       Impact factor: 2.379

3.  Visual evoked potential in the management of pituitary tumor during pregnancy.

Authors:  Y Mashima; Y Oguchi
Journal:  Doc Ophthalmol       Date:  1987-01       Impact factor: 2.379

Review 4.  The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.

Authors:  Ewelina Lachowicz; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2018-10-29       Impact factor: 2.379

5.  The electrophysiological tests in the early detection of the visual pathway dysfunction in patients with microadenoma.

Authors:  Ewelina Lachowicz; Wojciech Lubiński; Wojciech Gosławski; Elżbieta Andrysiak-Mamos; Agnieszka Kaźmierczyk-Puchalska; Anhelli Syrenicz
Journal:  Doc Ophthalmol       Date:  2021-03-20       Impact factor: 2.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.